1. Keerthi Brahmandam K, Kothamasu S, Makineni A, Nama S. Formulation and evaluation of sitagliptin phosphate gastro retentive tablets.
Caribb J Sci Tech. 2014;2:270-81. https://doi.org/10.1155/2019/3950942
2. Omar S, Aldosari B, Refai H, Gohary OA. Colon-specific drug delivery for mebeverine hydrochloride. J Drug Target. 2007 Dec;15(10):691-700. doi: 10.1080/10611860701603281. PMID: 18041637.
3. Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015 Aug;16(4):731-41. doi: 10.1208/s12249-015-0350-9. Epub 2015 Jun 13. PMID: 26070545; PMCID: PMC4508299.
4. Bayan MF, Bayan RF. Recent advances in mesalamine colonic delivery systems. Future J Pharm Sci. 2020;6(1):43. doi:10.1186/s433094-2--00057-7
5. Abinusawa A, Tenjarla S. Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels. Adv Ther. 2015 May;32(5):477-84. doi: 10.1007/s12325-015-0206-4. Epub 2015 May 8. PMID: 25951927; PMCID: PMC4449368.
6. Déo SC, Andreazza IF, Possamai JC. Development of mesalazine pellets coated with methacrylic-derived polymer. Braz J Pharm Sci. 2011;47:103-9. https://doi.org/10.1590/S1984-82502011000100013
7. Kaur G, Grewal J, Jyoti K, Jain UK, Chandra R, Madan J. Chapter 15 - Oral controlled and sustained drug delivery systems: Concepts, advances, preclinical, and clinical status. In: Grumezescu AM, editor. Drug Targeting and Stimuli Sensitive Drug Delivery Systems: William Andrew Publishing; 2018. p. 567-626. https://dx.doi.org/10.3390%2Fpharmaceutics11090436
8. Nesbitt RU, Goodhart FW, Gordon RH. Evaluation of polyvinyl acetate phthalate as an enteric coating material. Int J Pharm. 1985;26(3):215-26. https://doi.org/10.1016/0378-5173(85)90231-5
9. Shanmugam S. Granulation techniques and technologies: recent progresses. Bioimpacts. 2015;5(1):55-63. doi: 10.15171/bi.2015.04. Epub 2015 Feb 18. PMID: 25901297; PMCID: PMC4401168.
10. Agrawal R, Naveen Y. Pharmaceutical processing–A review on wet granulation technology. Int J Pharm Front Res. 2011 Apr;1(1):65-83.
11. Suresh P, Sreedhar I, Vaidhiswaran R, Venugopal A. A comprehensive review on process and engineering aspects of pharmaceutical wet granulation. Chem Eng J. 2017;328:785-815. http://doi.org/10.1016/j.cej.2017.07.091
12. Thapa P, Tripathi J, Jeong SH. Recent trends and future perspective of pharmaceutical wet granulation for better process understanding and product development. Powder Technol. 2019;344:864-82.
13. Basavaiah K, Rajendraprasad N, Vinay KB. Isocratic High-Performance Liquid Chromatographic Assay of Olanzapine: Method Development and Validation. ISRN Anal Chem. 2014;2014:616941. https://doi.org/10.1155/2014/616941
14. Patil GD, Tambe KP, Shirsat SP, Patil A. Review on enteric coated polymers. Res J Pharma Dosage Forms and Tech. 2021;13(1):82-5. 10.5958/0975.2021.00015.x
15. Mozafari N, Azadi S, Mohammadi Samani S, Farjadian F, Azadi A. Concurrent analysis of Simvastatin and citicoline using a Reversed-phase High Performance Liquid Chromatography-Ultra Violet Method. Trends in Pharmaceutical Sciences. 2019; 5(1): 41-46. doi: 10.30476/tips.2019.81749.1006.
16. Hiremath P, Nuguru K, Agrahari V. Chapter 8 - Material Attributes and Their Impact on Wet Granulation Process Performance. In: Narang AS, Badawy SIF, editors. Handbook of Pharmaceutical Wet Granulation: Academic Press; 2019. p. 263-315.
17. Efentakis M, Naseef H, Vlachou M. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Drug Dev Ind Pharm. 2010 Aug;36(8):903-16. doi: 10.3109/03639040903585119. PMID: 20196641.
18. Szumilo M, Belniak P, Swiader K, Holody E, Poleszak E. Assessment of physical properties of granules with paracetamol and caffeine. Saudi Pharm J. 2017 Sep;25(6):900-905. doi: 10.1016/j.jsps.2017.02.009. Epub 2017 Feb 16. PMID: 28951676; PMCID: PMC5605841.
19. Osamura T, Takeuchi Y, Onodera R, Kitamura M, Takahashi Y, Tahara K, Takeuchi H. Formulation design of granules prepared by wet granulation method using a multi-functional single-punch tablet press to avoid tableting failures. Asian J Pharm Sci. 2018 Mar;13(2):113-119. doi: 10.1016/j.ajps.2017.08.002. Epub 2017 Aug 10. PMID: 32104384; PMCID: PMC7032211.
20. Garbacz G, Klein S. Dissolution testing of oral modified-release dosage forms.
J Pharm Pharmacol. 2012 Jul;64(7):944-68. doi: 10.1111/j.2042-7158.2012.01477.x. Epub 2012 Feb 21. PMID: 22686342.